170 related articles for article (PubMed ID: 10412775)
1. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells.
Nogaki F; Muso E; Yashiro M; Kasuno K; Kamata T; Ono T; Sasayama S
Kidney Int Suppl; 1999 Jul; 71():S198-201. PubMed ID: 10412775
[TBL] [Abstract][Full Text] [Related]
2. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells.
Grandaliano G; Biswas P; Choudhury GG; Abboud HE
Kidney Int; 1993 Sep; 44(3):503-8. PubMed ID: 8231022
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
[TBL] [Abstract][Full Text] [Related]
6. Collagen secretion and growth of mesangial cells require geranylgeranylpyrophosphate.
Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
Kidney Int; 1999 Feb; 55(2):520-8. PubMed ID: 9987076
[TBL] [Abstract][Full Text] [Related]
7. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA.
Hänsch GM; Wagner C; Bürger A; Dong W; Staehler G; Stoeck M
J Cell Physiol; 1995 Jun; 163(3):451-7. PubMed ID: 7775588
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells.
Schnaper HW; Kopp JB; Poncelet AC; Hubchak SC; Stetler-Stevenson WG; Klotman PE; Kleinman HK
J Cell Sci; 1996 Oct; 109 ( Pt 10)():2521-8. PubMed ID: 8923213
[TBL] [Abstract][Full Text] [Related]
9. Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins).
Goppelt-Struebe M; Hahn A; Iwanciw D; Rehm M; Banas B
Mol Pathol; 2001 Jun; 54(3):176-9. PubMed ID: 11376131
[TBL] [Abstract][Full Text] [Related]
10. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
Guijarro C; Keane WF
Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
[TBL] [Abstract][Full Text] [Related]
11. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells.
Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR
Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307
[TBL] [Abstract][Full Text] [Related]
12. Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells.
Anderson PW; Zhang XY; Tian J; Correale JD; Xi XP; Yang D; Graf K; Law RE; Hsueh WA
Kidney Int; 1996 Sep; 50(3):745-53. PubMed ID: 8872947
[TBL] [Abstract][Full Text] [Related]
13. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
Haslinger B; Kleemann R; Toet KH; Kooistra T
Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
[TBL] [Abstract][Full Text] [Related]
15. Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression.
Grandaliano G; Ranieri E; Monno R; Gesualdo L; Schena F
Exp Nephrol; 1999; 7(3):229-35. PubMed ID: 10352363
[TBL] [Abstract][Full Text] [Related]
16. BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.
Wang S; Hirschberg R
Am J Physiol Renal Physiol; 2003 May; 284(5):F1006-13. PubMed ID: 12676736
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta.
Ruiz-Ortega M; Largo R; Bustos C; Gómez-Garre D; Egido J
J Am Soc Nephrol; 1997 Aug; 8(8):1266-75. PubMed ID: 9259353
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells.
Baricos WH; Cortez SL; Deboisblanc M; Xin S
J Am Soc Nephrol; 1999 Apr; 10(4):790-5. PubMed ID: 10203363
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities.
Sugiura T; Imai E; Moriyama T; Horio M; Hori M
Nephron; 2000 May; 85(1):71-80. PubMed ID: 10773759
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
